Chagas disease is still an important health problem in Central and South America. However, the only drugs currently available for specific treatment of this disease may induce toxic side effects in the host. The aim of this work was to determine the activity of N-benzenesulfonylbenzotriazole (BSBZT) against the protozoan parasite Trypanosoma cruzi. The effects of BSBZT and benzotriazole (BZT) were compared to those of benznidazole (BZL) on epimastigote and trypomastigote forms. BSBZT was found to have an in vitro growth inhibitory dose-dependent activity against epimastigotes, with flow cytometry analysis confirming that the treated parasites presented size reduction. BSBZT showed an IC50 of 21.56 μg/mL (81.07 μM) against epimastigotes at 7...
Currently, only two drugs (i.e. benznidazole (BZN) and nifurtimox (NFX)) have been approved for the ...
Chagas disease is a serious parasitic infection caused by Trypanosoma cruzi. Unfortunately, the curr...
Combination therapies based on the available drugs have been proposed as promising therapeutic alter...
BACKGROUND The current chemotherapy for Chagas disease is based on monopharmacology with low efficac...
BACKGROUND The current chemotherapy for Chagas disease is based on monopharmacology with low efficac...
The genotoxicity of benznidazole at a concentration of 75 µM, used in the treatment of Chagas’ disea...
Chagas' disease is caused by the protozoan parasite Trypanosoma cruzi. About 8. million people throu...
Combination therapy has been proposed as an ideal strategy to reduce drug toxicity and improve treat...
Chagas disease is included in the neglected tropical diseases list and is endemic to 21 Latin Ameri...
Chagas' disease, a neglected tropical infection, affects about 18 million people, and 100 million ar...
BACKGROUND The current chemotherapy for Chagas disease is based on monopharmacology with low efficac...
AbstractSynthetic thiosemicarbazones and semicarbazones were evaluated for their Trypanosoma cruzi t...
O parasita Trypanosoma cruzi (T. cruzi) é o causador da doença de Chagas e continua sendo um grave p...
Benznidazole (BZ) is a first-line drug for the treatment of Chagas disease; however, it presents sev...
Chagas disease, caused by Trypanosoma cruzi, is the main cause of dilated cardiomyopathy in the Amer...
Currently, only two drugs (i.e. benznidazole (BZN) and nifurtimox (NFX)) have been approved for the ...
Chagas disease is a serious parasitic infection caused by Trypanosoma cruzi. Unfortunately, the curr...
Combination therapies based on the available drugs have been proposed as promising therapeutic alter...
BACKGROUND The current chemotherapy for Chagas disease is based on monopharmacology with low efficac...
BACKGROUND The current chemotherapy for Chagas disease is based on monopharmacology with low efficac...
The genotoxicity of benznidazole at a concentration of 75 µM, used in the treatment of Chagas’ disea...
Chagas' disease is caused by the protozoan parasite Trypanosoma cruzi. About 8. million people throu...
Combination therapy has been proposed as an ideal strategy to reduce drug toxicity and improve treat...
Chagas disease is included in the neglected tropical diseases list and is endemic to 21 Latin Ameri...
Chagas' disease, a neglected tropical infection, affects about 18 million people, and 100 million ar...
BACKGROUND The current chemotherapy for Chagas disease is based on monopharmacology with low efficac...
AbstractSynthetic thiosemicarbazones and semicarbazones were evaluated for their Trypanosoma cruzi t...
O parasita Trypanosoma cruzi (T. cruzi) é o causador da doença de Chagas e continua sendo um grave p...
Benznidazole (BZ) is a first-line drug for the treatment of Chagas disease; however, it presents sev...
Chagas disease, caused by Trypanosoma cruzi, is the main cause of dilated cardiomyopathy in the Amer...
Currently, only two drugs (i.e. benznidazole (BZN) and nifurtimox (NFX)) have been approved for the ...
Chagas disease is a serious parasitic infection caused by Trypanosoma cruzi. Unfortunately, the curr...
Combination therapies based on the available drugs have been proposed as promising therapeutic alter...